To the central content area :::


Listed Companies

:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6919 Caliway
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
Hsu, Lu-Hui Ling, Yu-Fang Ling, Yu-Fang 02-2697-1355 32F-9, No.99, Sec. 1, Xintai 5th Rd., Xizhi Dist.,New Taipei City, Taiwan 2022/12/26
Key businesses
Biotechnology and Medical Care Caliway Biopharmaceuticals Inc. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small-molecule therapeutics. We also choose on areas of unmet medical need and target a growing market worth more than $10 billion to expand their market opportunity. Our leading candidate, CBL-514, is a first-in-class new drug that can trigger adipocyte apoptosis at the injection site and effectively reduce the subcutaneous fat without causing tissue necrosis or prominent side effects. The drug has completed Phase 2a trials for non-surgical fat reduction and has shown promising clinical effectiveness and safety and is expected to expand its indications to include Dercum’s disease and cellulite. Our other products in clinical development target osteoarthritis, diabesity, hyperpigmentation and aging skin. We believe Caliway will become a rising star in the Taiwanese pharmaceutical market.
Market info
Latest trading info Historic trading info
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
profit and loss
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.